Fragile X syndrome (FXS) is a broad-spectrum neurological disorder characterized by hypersensitivity to sensory stimuli, hyperactivity and severe cognitive impairment. FXS is caused by loss of the fragile X mental retardation 1 (FMR1) gene, whose FMRP product regulates mRNA translation downstream of synaptic activity to modulate changes in synaptic architecture, function and plasticity. Null Drosophila FMR1 (dfmr1) mutants exhibit reduced learning and loss of protein synthesis-dependent memory consolidation, which is dependent on the brain mushroom body (MB) learning and memory center. We targeted a transgenic GFP-based calcium reporter to the MB in order to analyze calcium dynamics downstream of neuronal activation. In the dfmr1 null MB, there was significant augmentation of the calcium transients induced by membrane depolarization, as well as elevated release of calcium from intracellular organelle stores. The severity of these calcium signaling defects increased with developmental age, although early stages were characterized by highly variable, low fidelity calcium regulation. At the single neuron level, both calcium transient and calcium store release defects were exhibited by dfmr1 null MB neurons in primary culture. Null dfmr1 mutants exhibit reduced brain mRNA expression of calcium-binding proteins, including calcium buffers calmodulin and calbindin, predicting that the inability to appropriately sequester cytosolic calcium may be the common mechanistic defect causing calcium accumulation following both influx and store release. Changes in the magnitude and fidelity of calcium signals in the absence of dFMRP likely contribute to defects in neuronal structure/function, leading to the hallmark learning and memory dysfunction of FXS.
Introduction
Fragile X syndrome (FXS) is the most common heritable mental retardation and autism disorder (Belmonte and Bourgeron, 2006; Clifford et al., 2007; Cohen et al., 2005; Hagerman et al., 2005; Rogers et al., 2001) , manifesting multiple activity-regulation defects including hyperactivity and childhood epileptic seizures (Freund and Reiss, 1991; Sabaratnam et al., 2001; Torrioli et al., 2008) . Consistently, FXS animal models display hyperactivity, audiogenic seizures and over-elaborated synaptic processes that are normally regulated in activity-dependent mechanisms (Comery et al., 1997; Galvez and Greenough, 2005; Galvez et al., 2005; Grossman et al., 2006; Nimchinsky et al., 2001 ). In addition, FXS models show defects in activity-dependent synaptic function, including brain region specific defects in long-term potentiation (LTP) and depression (LTD) (Godfraind et al., 1996; Huber et al., 2002; Koekkoek et al., 2005; Zhao et al., 2005) . Both activity-regulated synaptic structure and function defects are dependent on the stage of neural circuit maturation (Bureau et al., 2008; Harlow et al., 2010; Larson et al., 2005) .
FXS results from the loss of fragile X mental retardation protein (FMRP) whose function is completely conserved from Drosophila to humans (Coffee et al., 2010) . In both mammals and Drosophila, FMRP functions downstream of synaptic activity, including metabotropic glutamate receptor (mGluR) signaling and likely other neurotransmitter-gated Gq signaling mechanisms (Bear et al., 2004; Pan et al., 2008; Repicky and Broadie, 2009; Volk et al., 2007) . Likewise, FMRP expression is positively regulated by activity and repressed under conditions of reduced activity (Gabel et al., 2004; Tessier and Broadie, 2008; Valentine et al., 2000) . FMRP associates with polyribosomes in an activity-dependent manner to regulate protein synthesis (Aschrafi et al., 2005; Khandjian et al., 2004; Nosyreva and Huber, 2006; Stefani et al., 2004) . In all species, FMRP functions in mRNA translocation/stability and translational repression, most evidently during activity stimulation (Antar et al., 2004; Park et al., 2008; Todd et al., 2003; Zalfa et al., 2007; Zhang et al., 2001) . Membrane depolarization leads to increases in protein synthesis and mobilization of FMRP granules into synaptic regions (Antar et al., 2004; Muddashetty et al., 2007) . Thus, FMRP both responds to neuronal activity levels and mediates protein changes that modulate the Neurobiology of Disease 41 (2011) 147-159 
